Research Topics
| Donald R WessonSummaryCountry: USA Publications
| Collaborators |
Detail Information
Publications
The Clinical Opiate Withdrawal Scale (COWS)Donald R Wesson
CNS Medications Development, Oakland, California, USA
J Psychoactive Drugs 35:253-9. 2003..PDF formatted versions of the COWS are also available from the websites of the American Society of Addiction Medicine, the California Society of Addiction Medicine, the UCLA Integrated Substance Abuse Programs, and AlcoholMD.com...
Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.SDonald R Wesson
CNS Medications Development, Oakland, California, USA
J Psychoactive Drugs . 2004..Sublingual buprenorphine, and the combination of sublingual buprenorphine/naloxone, have unique pharmacological properties that make them a logical first-line intervention in the treatment of opioid dependence...
Buprenorphine in the treatment of opiate dependenceDonald R Wesson
CNS Medications Development, Oakland, CA, USA
J Psychoactive Drugs 42:161-75. 2010..This article reviews the pharmacology of buprenorphine, summarizes evidence supporting the safety and efficacy of buprenorphine and provides clinical guidelines for treatment...
Psychedelic drugs, hippie counterculture, speed and phenobarbital treatment of sedative-hypnotic dependence: a journey to the Haight Ashbury in the SixtiesDonald R Wesson
CNS Medications Development, Oakland, CA, USA
J Psychoactive Drugs 43:153-64. 2011..quot;..
